Xalkori 200 MG capsule 60S
Ended Awarded
- Contract number
- SPE2DB26FABR6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,419
Award facts
- Contract value 100% obligated
- $14,419.31 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $14,419.31 to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Xalkori 200 mg capsules (60-count packages). This is a firm fixed-price, non-set-aside contract with a completion date of December 2, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Xalkori is a targeted cancer therapy used in the treatment of certain lung cancers, reflecting the critical pharmaceutical supply needs of the Department of Defense and federal healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), a $999.999 billion comprehensive pharmaceutical supply vehicle running through December 2026. The prime IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products, medical supplies, and specialty medications to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen has demonstrated capability to fulfill competitive federal requirements through its extensive portfolio of brand-name and generic medications across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB26FABR6?
SPE2DB26FABR6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 7, 2025.
How much is contract SPE2DB26FABR6 worth?
The government has obligated $14,419 on SPE2DB26FABR6.
Is contract SPE2DB26FABR6 an order under another contract?
Yes. SPE2DB26FABR6 is a delivery order under SPE2DB22D3016, an indefinite delivery contract.
Was contract SPE2DB26FABR6 competed?
The extent of competition for SPE2DB26FABR6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award